ID-085

DRUG2 trials

Sponsors

Idorsia Pharmaceuticals Ltd.

Conditions

Healthy SubjectsRenal Impairment

Phase 1

A Study to Evaluate if ID-085 is Safe, Its Fate in the Body as Well as Its Potential Effects on the Body in Healthy Subjects

CompletedNCT03372629

Idorsia Pharmaceuticals Ltd.Healthy Subjects

Start: 2018-01-12End: 2018-12-02Updated: 2018-12-19

A Study to Evaluate ID-085 in People With Mild, Moderate, and Severe Kidney Disease

CompletedNCT03913000

Idorsia Pharmaceuticals Ltd.Renal Impairment

Start: 2019-04-29End: 2019-08-22Updated: 2019-11-22